WHERE TO FIND US THIS AUTUMN

Autumn Phone 1_maria-shanina-unsplash.jpg

Autumn is here! ‘tis the conference season.

The Vitaccess team is excited to share new findings of its digital studies in Melanoma and rare diseases Charcot-Marie-Tooth and Beta-Thalassemia.

We’re looking forward to presenting a short- course at ISPOR Europe on Saturday 2 November in the afternoon. Register here to attend.

We have had 10 abstracts approved and will be presenting the resulting posters at the conferences below.

Come and say hello at our poster presentations to discover more about our patient-centric studies.

Please note: all times are in local time

AMERICAN ASSOCIATION OF NEUROMUSCULAR & ELECTRODIAGNOSTIC MEDICINE ANNUAL MEETING

 
 

16-19 October - Austin, Texas

 Thursday, 17 October: 1300-1330 and 1530-1600

  • 83: Treatment of Charcot–Marie–Tooth disease in the United Kingdom and United States: insights from a digital real-world observational study

Friday, 18 October: 1300-1330 and 1530-1600

  • 200: Diversity in the Charcot–Marie–Tooth disease population in the United Kingdom and United States: insights from a digital real-world observational study


ISOQOL (Anna's) Poster Presentation post image.JPG

20-23 October – San Diego, California

 Monday 21 October 2019: 15:20 - 16:00

  • 1036: Challenges in localization of patient-reported outcomes instruments destined for smartphone applications

Wednesday 23 October 2019: 15:25 - 16:05

  • 3024: The patient’s voice. Innovation in the localization methodology of real-world evidence ‘Bring Your Own Device’ smartphone apps for quality of life observational studies


isporeurope2019_730x90.jpg

If you can’t attend our short course or our poster presentations, we’ll be at booth C2-025 where we’ll demo our study apps.

SHORT COURSE

Saturday, 2 November: 13:00-17:00

Short-course presentation by Dr Mark Larkin, Jon Spinage and Dr Annabel Nixon

  • Digital real-world evidence generation approaches in rare diseases and oncology

POSTERS

Monday, 4 November: 15:30-18:00

  • PCN265: Targeted review of adverse events associated with treatments for stage 3 and 4 Melanoma

Wednesday, 6 November: 09:30-14:00

  • PRO37: Healthcare resource use in Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world study

  • PRO93: Demographics and treatment patterns for Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world study

  • PRO116: Understanding the role of real-world evidence in Health Technology Assessment for orphan drugs

  • PRO136: Patient-reported burden of transfusion-dependent Beta-Thalassemia in the USA and UK measured using a digital app

  • PRO138: Productivity losses in people with Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world evidence study

Coralie Rassinoux